{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-012287","form_type":"8-K","ticker":"SEER","cik":"0001726445","company_name":"Seer, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.025905+00:00","generated_at":"2026-06-26T00:49:58.687437+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Seer reports Q1 revenue $3.3M, net loss $23.6M; reaffirms FY2022 guidance $14-16M","bullets":["Revenue $3.3M (vs $62K Q1 2021); product revenue $3.2M incl. $1.1M related-party.","Net loss $23.6M (vs $16.4M); operating expenses $25.0M incl. $8.1M stock-based comp.","Cash, cash equivalents and investments $472M as of March 31, 2022.","FY2022 revenue guidance reaffirmed at $14.0-16.0M; increasing investments in commercial, R&D.","Hired Scott Thomas as Chief Commercial Officer; PNAS publication on Proteograph performance."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-012287","json":"https://secwatch.observer/filing/0001628280-22-012287.json","markdown":"https://secwatch.observer/filing/0001628280-22-012287.md","text":"https://secwatch.observer/filing/0001628280-22-012287.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726445/000162828022012287/0001628280-22-012287-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726445/000162828022012287/seer-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:49:58.687437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}